CFP
TEVA icon

Cornerstone Financial Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Cornerstone Financial Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-48,742
Closed -$1.77M – 169
2016
Q4 		$1.77M Buy
+48,742
New +$1.95M 0.57% 49
2016
Q3 		– Sell
-7,887
Closed -$397K – 171
2016
Q2 		$397K Buy
7,887
+284
+4% +$15.1K 0.14% 115
2016
Q1 		$408K Buy
+7,603
New +$446K 0.16% 110

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cornerstone Financial Partners's TEVA Position: Q1 2017 in Review

Cornerstone Financial Partners sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 48,742 shares — an estimated $1.77M sold.

Cornerstone Financial Partners first reported a position in TEVA in Q1 2016 and held it in 3 quarters. The position peaked at $1.77M in Q4 2016. 686 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Cornerstone Financial Partners reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Cornerstone Financial Partners sold 48,742 Teva Pharmaceuticals shares in Q1 2017, an estimated $1.77M.
  • Cornerstone Financial Partners first reported a position in Teva Pharmaceuticals in Q1 2016 and held it in 3 quarters.
  • Cornerstone Financial Partners's Teva Pharmaceuticals position peaked at $1.77M in Q4 2016.
  • 686 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Cornerstone Financial Partners's 13F filing for Q1 2017, filed 17 Apr 2017.